Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19

Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19

Abstract Background COVID-19, the pandemic disease caused by infection with SARS-CoV-2, may take highly variable clinical courses, ranging from symptom-free and pauci-symptomatic to fatal disease. The goal of the current study was to assess the association of COVID-19 clinical courses controlled by...

Full description

Bibliographic Details
Main Authors: Johannes C. Fischer, Albrecht G. Schmidt, Edwin Bölke, Markus Uhrberg, Verena Keitel, Torsten Feldt, Björn Jensen, Dieter Häussinger, Ortwin Adams, E. Marion Schneider, Vera Balz, Jürgen Enczmann, Jutta Rox, Derik Hermsen, Karin Schulze-Bosse, Detlef Kindgen-Milles, Wolfram Trudo Knoefel, Martijn van Griensven, Jan Haussmann, Balint Tamaskovics, Christian Plettenberg, Kathrin Scheckenbach, Stefanie Corradini, Alessia Pedoto, Kitti Maas, Livia Schmidt, Olaf Grebe, Irene Esposito, Anja Ehrhardt, Matthias Peiper, Bettina Alexandra Buhren, Christian Calles, Andreas Stöhr, Artur Lichtenberg, Noemi F. Freise, Matthias Lutterbeck, Amir Rezazadeh, Wilfried Budach, Christiane Matuschek
Format: Article
Language:English
Published: BMC 2021-09-01
Series:European Journal of Medical Research
Subjects:
SARS-CoV-2
HLA class I genotypes
ABO blood group
Chemokine receptor
CCR5
Neutralizing antibodies
Online Access:https://doi.org/10.1186/s40001-021-00560-4

Internet

https://doi.org/10.1186/s40001-021-00560-4

Similar Items